Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases

Atherosclerosis

Volumn 198, Issue 1, 2008, Pages 237-246

  Nakajima, Katsuyuki ^a,b   Nakajima, Yasuhiro ^b   Takeichi, Sanae ^a   Fujita, Masaki Q ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular events; Coronary artery atherosclerosis; Fatal clinical events; LDL C; Pokkuri death syndrome; Postprandial remnant hyperlipoporteinemia; Remnant like lipoprotein particle cholesterol (RLP C); Remnant like lipoprotein particle TG; Sudden cardiac death

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIKE LIPOPROTEIN PARTICLE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; CALCULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; FEMALE; HUMAN; INCIDENCE; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

ADULT; AGED; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; JAPAN; LIPOPROTEINS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 40949130514     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.016     Document Type: Article

References (33)

1. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 148 (1988) 36-69
2. The Scandinavian Sinvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Sinvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
3. Steinberg D., Parthasarathy S., Crew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenecity. N Engl J Med 320 (1989) 915-924
4. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 154 (2001) 229-236
5. Twickler T.B., Dallinga-Thie G.M., Cohn J.S., and Chapman M.J. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 109 (2004) 1918-1925
6. Nakajima K., Nakano T., and Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 367 (2006) 36-47
7. Sakata K., Miho N., Shirotani M., Yoshida H., and Takada A. Remnant-like particles cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis 136 (1998) 225-231
8. Miwa K., Makita T., Ihsii K., Okuda N., and Taniguchi A. High remnant lipoprotein levels in patients with variant angina. Clin Cardiol 27 (2004) 338-425
9. Kasteline J.J., Jukema I.W., Zwinderman A.H., et al. Lipoprotein lipase activity is associated with severity of angina pectoris. Circulation 102 (2000) 1629-1633
10. Igarashi Y., Tamura Y., Suzuki K., et al. Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. Coron Artery Dis 4 (1993) 177-185
11. Takeichi S., Nakajima Y., Yukawa N., et al. Association of plasma triglyceride-rich lipoprotein remnants with "Pokkuri disease". Legal Med 3 (2001) 84-94
12. Takeichi S., Nakajima Y., Osawa M., et al. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int J Legal Med 110 (1997) 213-219
13. Takeichi S., Yukawa N., Nakajima Y., et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary artery atherosclerosis in cases of sudden cardiac death. Atherosclerosis 142 (1999) 309-315
14. Nakajima K., Nakajima Y., Takeichi S., and Fujita M.Q. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases. Atherosclerosis 194 (2007) 473-483
15. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti A-1 immunoaffinity mixed gels. Clin Chim Acta 223 (1993) 53-71
16. Saniabadi A.R., Takeichi S., Yukawa N., et al. Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report. Thromb Haemost 79 (1998) 878-879
17. Ohara N., Takeichi S., Naito Y., et al. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthetase activity and attenuate endothelium-dependent vasorelaxation. Clin Chim Acta 338 (2003) 151-156
18. Oi K., Shimokawa H., Hiroki J., et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol 24 (2004) 918-92211
19. Miyata K., Shimokawa H., Kandabashi T., et al. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol 20 (2000) 2351-2358
20. Fuster V., Badimon J., Chesebro J.H., et al. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis 26 Suppl 4 (1996) 269-284
21. Takeichi S., Nakajima Y., Yukawa N., et al. Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death. Clin Chim Acta 343 (2004) 93-103
22. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
23. Sugai M. A pathological study on sudden and unexpected death, especially on the cardiac death autopsied by medical examiners in Tokyo. Acta Pathol Japon 9 (1959) 723-752
24. Gotoh K. A histological study on the conduction system of the so-called "Pokkuri disease" (sudden unexpected cardiac death of unknown origin in Japan). Jpn Circ J 40 (1976) 753-768
25. Takeichi S., and Fujita M.Q. Unveiling the cause of Pokkuri Disease-proposal of the concept for "Pokkuri Death" Syndrome (in Japanese). Igaku No Ayumi 217 4 (2006) 347
26. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20 6 (1992) 1391-1396
27. Bezzina C., Veldkamp M.W., Van den Berg M.P., et al. A single Na-channel mutation causing both long-QT and Brugada syndromes. Circ Res 85 (1999) 1206-1213
28. Priori S.G., Napolitano C., Schwartz P.J., et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 102 (2000) 945-947
29. Koo C., Wernette-Hammond M.E., Garcia Z., et al. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J Clin Invest 81 5 (1988) 1332-1340
30. Schaefer E.J., McNamara J.R., Tayler T., et al. Comparison of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Am J Cardiol 93 (2004) 31-39
31. Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group (VA-HIT). N Engl J Med 341 (1999) 410-418
32. Nordestrgaad B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 (2007) 309-316
33. Bansal S., Buring J.E., Rifai N., et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316